Czech National Bank Has $16.12 Million Stake in Corteva, Inc. $CTVA

Czech National Bank boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 3.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 190,372 shares of the company’s stock after buying an additional 7,213 shares during the period. Czech National Bank’s holdings in Corteva were worth $16,123,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CTVA. Arbejdsmarkedets Tillaegspension bought a new stake in Corteva during the fourth quarter worth about $23,679,000. Leonteq Securities AG bought a new position in shares of Corteva in the fourth quarter valued at approximately $2,350,000. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Corteva by 23.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after acquiring an additional 20,957 shares during the last quarter. Brandes Investment Partners LP boosted its holdings in shares of Corteva by 1.1% in the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares in the last quarter. Finally, Twin Capital Management Inc. grew its position in Corteva by 178.9% during the 4th quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock worth $1,702,000 after acquiring an additional 16,288 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.1%

Shares of CTVA opened at $76.95 on Friday. The business’s fifty day moving average price is $81.93 and its two-hundred day moving average price is $79.82. The firm has a market capitalization of $51.34 billion, a price-to-earnings ratio of 50.96, a PEG ratio of 2.36 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the company posted $2.20 earnings per share. The firm’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday. UBS Group increased their target price on Corteva from $86.00 to $89.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. BNP Paribas Exane raised their target price on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Barclays lifted their price target on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Finally, BMO Capital Markets increased their price objective on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $91.70.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.